taxanes
Showing 26 - 50 of 461
Peripheral Neuropathy Due to Chemo Trial in Mansoura (Venlafaxine 75 MG, Gabapentin 400 mg)
Recruiting
- Peripheral Neuropathy Due to Chemotherapy
- Venlafaxine 75 MG
- Gabapentin 400 mg
-
Mansoura, Dakahlia, EgyptMit Ghamr Oncology Center
May 16, 2023
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Breast Cancer, Neuropathy Trial in Ankara (Hand and foot exercise)
Recruiting
- Breast Cancer
- Neuropathy
- Hand and foot exercise
-
Ankara, TurkeyHealth Science University
Sep 23, 2023
HER2-positive Recurrent/Metastatic Breast Cancer Trial (Inetetamab, pyrotinib, chemo)
Not yet recruiting
- HER2-positive Recurrent/Metastatic Breast Cancer
- Inetetamab, pyrotinib, chemotherapy
- (no location specified)
Nov 16, 2022
Pain Cancer, Joint Pain Trial in TaoYuan (Laser acupuncture device, Pseudo-laser acupuncture)
Recruiting
- Pain Cancer
- Joint Pain
- Laser acupuncture device
- Pseudo-laser acupuncture
-
TaoYuan, TaiwanChangGung Memorial Hospital
Jul 29, 2021
Addition of Docetaxel to Standard Treatment in First-line
Completed
- HER2-positive Gastric Cancer
- +3 more
-
Besançon, Franche-Comté, FranceCHU Besancon
Jun 4, 2021
pCR After Neoadjuvant Therapy in Breast Cancer Patients
Recruiting
- Breast Cancer
- TIL assessment in pre-existing histopathological specimens
-
Cairo, EgyptFaculty of Medicine, Ain Shams University
Jul 25, 2022
Breast Cancer, Adenocarcinoma Trial in Switzerland (Eribulin mesilate)
Terminated
- Breast Cancer
- Adenocarcinoma
- Eribulin mesilate
-
Aarau, Switzerland
- +25 more
Sep 27, 2021
Chemo-Related Cognitive Impairment, Breast Cancer Trial in Guangzhou (Ganglioside-Monosialic Acid, 250ml normal saline (NS))
Recruiting
- Chemotherapy-Related Cognitive Impairment
- Breast Cancer
- Ganglioside-Monosialic Acid
- 250ml normal saline (NS)
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 25, 2022
Chemo-induced Peripheral Neuropathy Trial (Methadone)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- (no location specified)
Mar 27, 2023
Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon
Not yet recruiting
- Breast Cancer
- +4 more
- SV-BR-1-GM
- +4 more
-
Port Jefferson Station, New YorkNew York Cancers & Blood Specialists
Oct 2, 2023
Satisfaction & Efficacy of Compression Using Surgical Gloves in
Active, not recruiting
- Breast Cancer
- Colorectal Cancer
- Chilled gloves
- Surgical gloves
-
Caluire-et-Cuire, France
- +1 more
Nov 21, 2022
Neuropathy;Peripheral Trial in Houston (Abbott® DRG / Abbott®/Medtronic® SCS, Control Group)
Recruiting
- Neuropathy;Peripheral
- Abbott® DRG / Abbott®/Medtronic® SCS
- Control Group
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2023
Breast Cancer Trial in Amsterdam (carboplatin, thiotepa, and cyclophosphamide, chemo (docetaxel, doxorubicin, cyclofosfamide,
Recruiting
- Breast Cancer
- carboplatin, thiotepa, and cyclophosphamide
- chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
-
Amsterdam, NetherlandsNKI-AVL
Mar 21, 2022
HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Shanghai (Trastuzumab plus chemo, Trastuzumab in combination with
Recruiting
- HER2-positive Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab plus chemotherapy
- Trastuzumab in combination with pyrotinib plus chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 20, 2022
Triple-Negative Breast Cancer Trial in Guangzhou (DCb (docetaxel/carboplatin) versus EC followed by D
Completed
- Triple-Negative Breast Cancer
- DCb (docetaxel/carboplatin) versus EC followed by D (epirubicin/cyclophosphamide followed by docetaxe)
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Aug 27, 2022
Chemo-induced Peripheral Neuropathy Trial in Loma Linda (Arm 1: Investigational INF, Arm 2: standardized muscle stretching and
Active, not recruiting
- Chemotherapy-induced Peripheral Neuropathy
- Arm 1: Investigational INF
- Arm 2: standardized muscle stretching and strength
-
Loma Linda, CaliforniaLoma Linda Medical Center
Dec 21, 2022
Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Stage II and
Recruiting
- Breast Cancer
- Breast Cancer Stage II-III
- Docetaxel- Carboplatin
-
Madrid, SpainHospital Universitario Gregorio Marañon
Aug 24, 2021
Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma Trial in Spain, United States (MLN1117, TAK-659, Alisertib)
Terminated
- Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma
- MLN1117
- +4 more
-
Lake Success, New York
- +5 more
Aug 19, 2019
Advanced Adenocarcinoma, Metastatic Adenocarcinoma Trial in Philadelphia (Hydroxychloroquine (HCQ), Gemcitabine, Abraxane)
Completed
- Advanced Adenocarcinoma
- Metastatic Adenocarcinoma
- Hydroxychloroquine (HCQ)
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 29, 2022
Chemo-induced Peripheral Neuropathy Trial in Assiut (transcranial dirrect current brain stimuation)
Recruiting
- Chemotherapy-induced Peripheral Neuropathy
- transcranial dirrect current brain stimuation
-
Assiut, EgyptSouth Egypt Cancer Institute
Apr 3, 2021